Pharmaceutical, healthcare, medical & sales jobs
*Order all
your Pharmaceutical, Healthcare, Medical & Scientific books at
Amazon
| |
|
|
Pharmaceutical, healthcare, medical & sales jobs
|
|
|
|
|
|
|||||||||
|
Categories |
Pharmaceutical NewsLatest Pharmaceutical NewsGSK plans to enter generics market GlaxoSmithKline unveiled a strategic overhaul that includes a plan to sell a wide range of generic medicines under a pioneering deal to boost sales in emerging markets Prescription drug sales boost Pfizer Pfizer reported earnings in the second quarter more than doubled on higher sales of its prescription drugs and lower expenses, but the group has been hurt by steady declines in US sales Why the U-turn is a high-risk tactic It often happens when a big company takes over a small one. The acquirer insists its new subsidiary will be left alone and managers will be free to carry on as before. Then, one day, the long leash becomes a short one, writes John Gapper GSK experimental drugs face scrutiny GlaxoSmithKline is opening its portfolio of experimental drugs to external scrutiny in an attempt to develop more successful medicines. Experts hail new prostate cancer drug Europe's largest cancer research group gives an enthusiastic endorsement to abiraterone, which could benefit men diagnosed with the most aggressive form of prostate cancer Drugmakers dented by study findings Shares of drugmakers Schering-Plough and Merck fell sharply following release of a study that showed that Vytorin, a jointly marketed cholesterol drug, failed to improve a rare heart condition GSK in A$20m Relenza settlement The payout, for allegedly failing to market the flu drug, will be disappointing to shareholders of Biota, the Australian biotech business Sanofi-Aventis to buy Primary Health unit French drugmaker to deepen its presence in the Australian healthcare sector via agreement to acquire Primary Health's consumer business for A$560m Testing time for Roche There have always been tensions between Swiss group and Genentech, the US biotech company it is bidding to buy outright Roche launches $44bn Genentech offer Swiss drugs group offers to acquire stake in its US biotech partner it does not already own, as it reports 2% fall in first-half net profit Shire cuts tax bill by moving its HQ Pharmaceuticals company says its move to Ireland this year means it will avoid paying extra tax that would have been imposed under new UK rules Ranbaxy probe highlights medical issues The probe into the Indian generic drugs group has become a drawn-out battle for extra information with repercussions for the pharmaceuticals industry worldwide Elan ponders future of drugs unit Strategic review could see group's development and manufacturing division floated or sold with a price tag of up to $1.5bn Teva to buy Barr for $7.5bn Acquisition will boost Israeli group's position as the largest seller of off-patent medicines Advent buys Craegmoor for £290m The sale, which is expected to close on Friday amid delays due to the care home operator's complex capital structure, comes four months after it was put on the market Levonorgestrel completes Japanese Phase III trial Japanese biopharmaceutical company Sosei has announced that its emergency contraceptive pill, NorLevo (levonorgestrel) has completed a Phase III trial... more First organ-specific MRI contrast agent approved in the US in over a decade. The US FDA has granted Bayer Schering Pharma marketing approval for its magnetic resonance imaging (MRI) contrast agent, gadoxetate disodium... more Myriad terminates Phase III Alzheimer's disease therapy US-based Myriad Genetics has announced that it has discontinued development of tarenflurbil (Flurizan)... more Novexel discontinues MRSA agent Novexel has discontinued the development of its antibacterial agent, NXL-101 due to adverse events in a Phase I trial... more GlaxoSmithKline makes cancer cell genomic data available to all cancer researchers GlaxoSmithKline has released genomic profiling data for over 300 cancer cell lines via the US National Cancer Institute's cancer Bioinformatics Grid initiative... more Genzyme files plerixafor in the EU and the US Genzyme has filed for approval of its chemokine inhibitor plerixafor (Mobozil) in both the EU and US markets... more AstraZeneca submits sNDA for Seroquel XR for generalized anxiety disorder AstraZeneca's sustained release formulation of quetiapine fumarate (Seroquel XR) is now awaiting approval in the US for the treatment of generalised anxiety disorder (GAD)... more World Asthma Day "You Can Control Your Asthma" was the theme of this year's World Asthma Day... more Cimzia approved in the US for moderate-to-severe Crohn's disease UCB has announced that the US FDA has approved Cimzia (certolizumab pegol), the first and only PEGylated anti-TNFalpha antibody for use in Crohn's disease... more Perampanel development for Parkinson's disease terminated at Phase III Perampanel (E-2007), Eisai's non-competitive AMPA-type glutamate receptor antagonist, has been discontinued for the treatment of Parkinson's disease... more Latest updates: |
||||||||
|
|
|||||||||
|
|||||||||
|
| |
|
|
Copyright ©. All rights reserved. Pharmaceutical.org.uk |
|
 |
|
|
Other Pharmaceutical sites: JobsPharm.com | AllAboutMedicalSales.com | Pharmaceutical-Company.co.uk | Pharm.co.uk |
|
 |
|
